Matricelf Ltd (TASE: MTLF)
Health Care · Biotechnology · IL
₪2.60
+4.20% today · -38.7% 1Y
Matricelf Ltd (TASE: MTLF) operates in the Biotechnology industry within the Health Care sector. The company is valued at $27.79M and employs 15 people.
Over the last twelve months the share price has lost 38.7%, trading between 2.12 and 8.53.
Tweenvest scores Matricelf Ltd across four factors: quality 44/100, value 66/100. Its strongest factor is value.
MTLF price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $27.79M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.06
- Dividend yield
- —
- Beta (5Y)
- 0.37
- 52-week high
- ₪8.53
- 52-week low
- ₪2.12
- Avg volume (3M)
- —
- Shares outstanding
- 33.09M
- Employees
- 15
- Next earnings
- —
About Matricelf Ltd
Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company’s regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson’s disease, and myocardial infarction, as well as for 3D bioprinting. The company has a strategic collaboration with Sheba Medical Center for the development and clinical advancement of its neural tissue implant product for the treatment of spinal cord injury. The company has a strategic collaboration with CiRA Foundation for the development of regenerative manufacturing technologies and the evaluation of iPSC-based neural tissue engineering for therapeutic applications. The company was incorporated in 2019 and is based in Ness Ziona, Israel.
- ISIN
- IL0011767915
- Founded
- 2019
- Listed since
- Jun 21, 2021
- Exchange
- The Tel-Aviv Stock Exchange
- Currency
- ILS
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| TransCode Therapeutics, Inc.NasdaqCM: RNAZ | $28.78M | $1.70 | -8.60% |
| Amplia Therapeutics LimitedASX: ATX | $28.57M | AU$0.08 | -23.81% |
| NextCure, Inc.NasdaqGS: NXTC | $28.56M | $6.24 | -13.09% |
| Intervacc AB (publ)OM: IVACC | $28.25M | Skr0.82 | -7.44% |
| Zenotech Laboratories LimitedBSE: 532039 | $27.69M | Rs43.06 | -0.02% |
| Kohjin Bio Co., Ltd.TSE: 177A | $27.45M | ¥848.00 | +4.05% |
| Chordia Therapeutics Inc.TSE: 190A | $27.40M | ¥56.00 | -1.75% |
| IMB Dx, Inc.KOSDAQ: A461030 | $27.39M | ₩2,605.00 | -8.44% |
Figures last refreshed Oct 18, 2026.